Yusimry 40 mg/0.8 mL single-dose pen Images
Generic Name: adalimumab
This medication has been identified as Yusimry 40 mg/0.8 mL single-dose pen. It is supplied by Coherus BioSciences, Inc.
Yusimry is used in the treatment of Ankylosing Spondylitis; Crohn's Disease, Active; Crohn's Disease, Maintenance; Crohn's Disease; Hidradenitis Suppurativa and belongs to the drug class TNF alfa inhibitors. There is no proven risk in humans during pregnancy. Yusimry 40 mg/0.8 mL single-dose pen is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Yusimry
- Generic Name
- adalimumab
- Strength
- 40 mg/0.8 mL single-dose pen
- Availability
- Prescription only
- Drug Class
- TNF alfa inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Coherus BioSciences, Inc.
- National Drug Code (NDC)
- 70114-0220
More about Yusimry (adalimumab)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: TNF alfa inhibitors
- Breastfeeding
Patient resources
Other brands
Humira, Amjevita, Hadlima, Hyrimoz, ... +6 more
Professional resources
Other brands
Humira, Amjevita, Hadlima, Hyrimoz, ... +6 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.